Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies

Volume: 18, Pages: 152 - 160
Published: Dec 1, 2021
Abstract
The Covid-19 disease has recently become one of the biggest challenges globally, and there is still no specific medication. Findings showed the immune system in severe Covid-19 patients loses regulatory control of pro-inflammatory cytokines, especially IL-6 production, called the "Cytokine storm" process. This process can cause injury to vital organs, including lungs, kidneys, liver, and ultimately death if not inhibited. While many treatments...
Paper Details
Title
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
Published Date
Dec 1, 2021
Volume
18
Pages
152 - 160
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.